Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence RLLLPGELAKHAVSEGTKAV
Primary information
sequence IDSeq_6613
Peptide sequenceRLLLPGELAKHAVSEGTKAV
CancerPDF_ID CancerPDF_ID6688, CancerPDF_ID6689, CancerPDF_ID6690,
PMID24982608,24982608,24982608
Protein NameHistone H2B type 1-C/E/F/G/I,Histone H2B type 1-K,Histone H2B type 1-L
UniprotKB Entry NameH2B1C_HUMAN,H2B1K_HUMAN,H2B1L_HUMAN
FluidUrine,Urine,Urine
M/ZNA,NA,NA
ChargeNA,NA,NA
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueNano-LC-MS,Nano-LC-MS,Nano-LC-MS
Peptide Identification techniqueMS/MS,MS/MS,MS/MS
Quantification TechniqueNA,NA,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDR0.01,0.01,0.01
CancerPDF_ID CancerPDF_ID6688, CancerPDF_ID6689, CancerPDF_ID6690,
p-ValueNA,NA,NA
Software"GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT"
Length20,20,20
Cancer TypeOvarian cancer,Ovarian cancer,Ovarian cancer
DatabaseIPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database
ModificationNA,NA,NA
Number of Patients6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals
RegulationUniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients
ValidationNA,NA,NA
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasPeptideAtlas
IEDB